// App-Quantinova.ai

23 : Mutational Profile and Prognostic Relevance of Circulating Tumor Cells in Multiple Myeloma

Researchers

Presenter

  • Yuji Mishima

Principal Investigators

  • Bruno Paiva

  • Jiantao Shi

  • Antonio Sacco

  • Diego Alignani

  • Maria Victoria Mateos

  • Mira Massoud

  • Salomon Manier

  • Ludmila Flores

  • Adriana Perilla-Glen

  • Yosra Aljawai

  • Daisy Huynh

  • Satoshi Takagi

  • Aldo M Roccaro

Medical Centers

  • Harvard Medical School and Dana-Farber Cancer Institute, Boston, MA

  • Dana-Farber Cancer Institute, Boston, MA

  • Amyloidosis and Myeloma Unit, Department of Hematology, Servei dHematologia, Hospital Clinic de Barcelona, Institut dInvestigacions Biomediques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain

  • Hospital Doce de Octubre, Madrid, Spain

  • Clinica Universidad de Navarra, Pamplona, Spain

  • Hematology, Hospital Clinico Universitario de Salamanca-IBSAL, Salamanca, Spain

  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

  • Broad Institute, Dana-Farber Cancer Institute/Harvard Medical School, Boston, MA

Locations

  • United States

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved